The American Society for Clinical Pathology (ASCP) and the Joint Commission have established the Leading Laboratories Recognition Program — a designation that promotes laboratory leadership and helps elevate the visibility and collaborative work of the medical laboratory team among clinical colleagues, hospital leadership and patients.
The organizations said that “the designation, available to Joint Commission-accredited laboratories, is a symbol of laboratory excellence and provides visible and public recognition of a laboratory’s meaningful achievements in improving patient outcomes. It also serves as proof of a laboratory’s trusted leadership and commitment to the necessary ongoing professional development of its team that is critical to the continued delivery of effective, high-quality care,” according to a news release from the Joint Commission.
Leading Laboratories was developed and refined by laboratory leaders, the organizations said. The designation is accomplished through a set of criteria designed to quantify and exhibit the capability of a given laboratory to achieve high quality outcomes, assure professional development, engage in trusted leadership and earn laboratory visibility.
The Leading Laboratories Recognition Program will also provide a model and roadmap to help laboratories on their journey to achieve this designation. The recognition program will support ASCP and The Joint Commission’s shared mission of patient safety and quality, while providing another way to confirm laboratories’ essential role in the continuum of care across all health care settings.
Applications for the Leading Laboratories Recognition Program will begin to be accepted on October 27, 2021. To learn more, visit www.leadinglaboratories.org.
